Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
Clinical trial NCT05243329 · UNKNOWN
Trial details
- NCT number
- NCT05243329
- Sponsor
- Halucenex Life Sciences Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2023-10-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.